Evolent Health, Inc. EVH Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$496.52M-356% | -$534.51M-767% | -$128.18M-77.5% | -$130.45M-75.3% | -$108.96M+1.2% | ||
| $113.35M+0.4% | $115.85M-2.1% | $100.11M-15.6% | $106.2M-12.5% | $112.93M-8.7% | ||
| $39.31M— | $39.74M— | —— | —— | —— | ||
| -$2.7M+6.1% | -$2.98M+0.2% | -$1.02M+94.0% | -$2.58M+88.9% | -$2.88M+88.2% | ||
| $9.6M+151% | $7.8M+120% | $5.66M+59.4% | $4.19M+14.3% | $3.82M+1.0% | ||
| —— | —— | $24.49M— | $37.77M— | $15.93M— | ||
| —— | —— | —— | —— | -$53.71M— | ||
| -$9.35M— | -$4.99M— | —— | —— | —— | ||
| $4.83M+1,692% | $5.03M+870% | $540K+238% | $351K+173% | -$303K+44.6% | ||
| $2K+101% | $0+100% | $0+100% | -$168K-194% | -$176K-261% | ||
| -$3.6M-222% | -$1.3M+62.4% | -$750K+78.5% | -$2.23M+18.5% | -$1.12M+12.0% | ||
| $373K+109% | $365K+110% | $334K+109% | -$2.05M-201% | -$3.95M-437% | ||
| -$37.6M-147% | -$33.2M-122% | -$32.76M-91.0% | -$25.27M+1.8% | -$15.22M— | ||
| $6.78M— | $6.5M— | —— | —— | —— | ||
| $6.49M+34.3% | $6.79M+41.6% | $6.9M+5.4% | $5M-34.1% | $4.83M-51.0% | ||
| $33.29M— | $38.84M— | —— | —— | —— | ||
| $52.95M+56.5% | $57.45M+87.0% | $69.83M— | $80.83M— | $33.84M— | ||
| —— | —— | -$102.32M-109% | -$113.28M-219% | -$66.29M-119% | ||
| $280.48M+349% | $342.98M— | $229.26M-45.0% | $62.5M-85.4% | $62.5M-85.4% | ||
| $2.45M-58.9% | $5.23M-66.7% | $5.48M-66.5% | $5.62M-67.4% | $5.96M-65.0% | ||
| $6.55M-66.6% | $11.13M-44.6% | $15.93M-22.1% | $19.14M-6.2% | $19.58M-3.1% | ||
| —— | —— | —— | —— | —— | ||
| -$1.1M-554% | -$486K-112% | -$397K-258% | -$227K-19.5% | -$168K-0.6% | ||
| -$109.1M— | $2.2M— | —— | —— | —— | ||
| $9.6M+151% | $7.8M+120% | $5.66M+59.4% | $4.19M+14.3% | $3.82M+1.0% | ||
| $6.78M— | $6.5M— | —— | —— | —— | ||
| $6.49M+34.3% | $6.79M+41.6% | $6.9M+5.4% | $5M-34.1% | $4.83M-51.0% | ||
| —— | -$3.48M— | -$2.61M+50.3% | -$1.74M+83.4% | -$870.75K+94.5% | ||
| —— | —— | —— | —— | -$20.83M— | ||
| $373K+109% | $365K+110% | $334K+109% | -$2.05M-201% | -$3.95M-437% | ||
| —— | —— | —— | —— | —— | ||
| $6.89M+20.9% | $6.95M+14.8% | $4.86M-23.3% | $4.09M-35.8% | $5.69M-2.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$136.33M-290% | -$40.82M-124% | ||
| -$37.6M-147% | -$33.2M-122% | -$32.76M-91.0% | -$25.27M+1.8% | -$15.22M— | ||
| -$1.86M+24.9% | -$1.76M+46.0% | -$1.82M+77.9% | -$2.11M+87.9% | -$2.48M— | ||
| $4.83M+1,692% | $5.03M+870% | $540K+238% | $351K+173% | -$303K+44.6% | ||
| -$9.35M— | -$4.99M— | —— | —— | —— | ||
| $2K+101% | $0+100% | $0+100% | -$168K-194% | -$176K-261% | ||
| $52.95M+56.5% | $57.45M+87.0% | $69.83M— | $80.83M— | $33.84M— | ||
| $31.9M+13.4% | $34.09M+36.9% | $32.48M+31.0% | $29.81M+17.8% | $28.14M+12.4% | ||
| —— | $91.31M— | $68.48M+47,376% | $45.66M+15,725% | $22.83M+5,175% | ||
| $6.01M— | $45.33M— | $2.38M— | —— | —— | ||
| $6.55M-66.6% | $11.13M-44.6% | $15.93M-22.1% | $19.14M-6.2% | $19.58M-3.1% | ||
| -$187.05M— | -$408.05M— | -$448.85M— | —— | —— | ||
| —— | —— | —— | —— | $62.5M-82.0% | ||
| -$3.6M-222% | -$1.3M+62.4% | -$750K+78.5% | -$2.23M+18.5% | -$1.12M+12.0% | ||
| -$37.6M-147% | -$33.2M-122% | -$32.76M-91.0% | -$25.27M+1.8% | -$15.22M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Evolent Health, Inc. generate?
- Evolent Health, Inc. (EVH) generated $33.3M in operating cash flow over the trailing twelve months.
- Where does Evolent Health, Inc.'s cash flow data come from?
- Every line is extracted from Evolent Health, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
